Clinical trial · Interventional
Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women
Weekly Cisplatin or Weekly Liposome Paclitaxel Concurrent Radiation Therapy in Treating Elderly People With Cervical Cancer
NCT01594099CI-TRIAL-00006872unknownPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the efficiency and safety of weekly Cisplatin /Liposome paclitaxel concurrent chemoradiothrapy in the treatment of locally advanced cervical cancer in elderly women.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cisplatin | Drug | Cisplatin | ALIAS |
| irradiation | Radiation | — | UNRESOLVED |
| liposome paclitaxel | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Radiotherapy alone
- interventionNames
- Radiation: irradiation
- type
- EXPERIMENTAL
- label
- Radiotherapy plus cisplatin
- interventionNames
- Drug: Cisplatin
- type
- EXPERIMENTAL
- label
- Radiotherapy plus liposome paclitaxel
- interventionNames
- Drug: liposome paclitaxel
Primary outcomes (2)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 65 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Histologically proven squamous carcinoma of cervix 2. FIGO stageⅡB and ⅢB 3. Over 65 years 4. Do not receive other treatment 5. Performance index ECOG grade 0 to 2 6. Normal ECG 7. Normal hematological parameters 8. Normal renal and liver function tests Exclusion Criteria: 1. Concomitant disease which may adversely affect the outcome 2. Poor nutritional status 3. Medical or psychological condition precluding treatment 4. Previous treatment 5. Concurrent treatment for any cancer
References
Publications (0)
Data not yet available
No reference posted for this study.